课题基金 / 基金详情

UROKINASE RECEPTOR EXPRESSION--COLON CANCER

UROKINASE RECEPTOR EXPRESSION--COLON CANCER
尿激酶受体表达——结肠癌
批准号:
6375960
负责人:
Douglas D. Boyd
金额:
$20.35万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 2003-04-30

项目摘要

项目成果

Douglas D. Boyd的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The goal of this application is to determine the mechanisms leading to the overexpression of the urokinase receptor (u-PAR) in invasive colon cancer. In Specific Aim 1, the applicant proposes to identify the role of an upstream AP-1 motif in the regulation of u-PAR expression and also identify transcription factors bound by this sequence. Aim 2 will ascertain the role of these promoter regions in regulating u-PAR expression by determining if deletion of either region impairs u-PAR promoter activity, by identifying the nucleotides contacted by nuclear proteins, and by determining the effect of mutation of the contacted nucleotides on u-PAR promoter activity. Aim 3 will determine the role of extracellular signal-regulated kinases 1 (ERK1) and 2 or a constitutively activated MEK1 which lies upstream of the ERKs, to modulate u-PAR expression and in vitro invasion. Aim 4 will investigate the ability of a synthetic inhibitor of MEK1 activation to downregulate u-PAR expression and in vitro invasion, and Aim 5 will determine the role of the c-Jun aminoterminal kinase 1 (JNK1) in regulating u-PAR expression. It is hoped that these studies will benefit colon cancer patients by decreasing u-PAR expression in colon cancer and thereby reduce the metastatic spread of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Src requirement for u-PAR expression by HGF and hypoxia
Src requirement for u-PAR expression by HGF and hypoxia
Src requirement for u-PAR expression by HGF and hypoxia
ROLE OF THE UROKINASE RECEPTOR IN INVASIVE COLON CANCER
海外基金